<DOC>
	<DOCNO>NCT02940925</DOCNO>
	<brief_summary>The purpose study compare survival toxicity TPC ( TAXOL , DDP AND CAPECITABINE ) VS PF ( cisplatin 5-Fluorouracil ) induction chemotherapy combine concurrent chemoradiotherapy ( CCRT ) stage IVa-b nasopharyngeal carcinoma patient endemic area .</brief_summary>
	<brief_title>TPC v PF Induction Chemotherapy Combined With CCRT Stage IVa-b Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>This prospective , parallel , randomized , open label , multicenter phase III clinical trial compare survival toxicity TPC VS PF induction chemotherapy combine CCRT stage IVa-b nasopharyngeal carcinoma patient endemic area.The primary endpoint failure free survival ( FFS）.The secondary endpoint overall survival ( OS） , progression-free survival（PFS） , local-regionally relapse free survival ( LRFS ) , distant metastasis free survival（DMFS ) toxicity .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>WHO II III pathological type stage Ⅳa Ⅳb ( UICC 7th edition ) anticancer treatment malignant history gender , 1860 year old enough liver function : TBIL≤ULN；AST/ALT≤2.5×ULN；ALP≤5×ULN enough kidney function : Clcr≥80 mL/min enough hemo : ANC≥2×109/L , PLT≥100×109/L HB≥9g/dL sever heart , lung disfunction PS≤2 previous anticancer treatment distant metastasis pregnant breast female access followup enrol therapeutic clinical trial sever infection internal disease sever disfunction heart , lung , kidney , liver , etc TBIL &gt; ULN；AST/ALT &gt; 2.5×ULN；ALP &gt; 5×ULN factor affect administration , distribution , metabolism evacuation . use immunosuppressive agent organ transplantation malignant history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Nasopharyngeal carcinoma</keyword>
	<keyword>induction chemotherapy</keyword>
</DOC>